Patents by Inventor Bente Frolund

Bente Frolund has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220339131
    Abstract: A compound for use in the treatment of CNS disorders with sleep disturbances e.g. narcolepsy or Angelman syndrome in a subject, wherein said compound is according to formula (I) or any isomer, tautomer, enantiomer, racemic form or deuterated form thereof, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 26, 2020
    Publication date: October 27, 2022
    Inventors: Petrine Wellendorph, Birgitte Rahbek Kornum, Bente Frølund
  • Publication number: 20210122700
    Abstract: The invention relates to a compound according to formula I wherein when R5 is H, and R1 and R2 form a ring system, then said compound is selected from the following compounds of formula II or formula IV or when R2 is H, and R1 and R5 form a ring system, then said compound has formula III
    Type: Application
    Filed: February 1, 2019
    Publication date: April 29, 2021
    Inventors: Anders Bue Klein, Andrew Neil Clarkson, Joshua Macdonald Houlton, Ulrike Leurs, Rasmus Prætorius Clausen, Bente Frølund, Petrine Wellendorph
  • Patent number: 6174909
    Abstract: The present invention relates to novel 4-aminotetrahydrobenzisoxazoles or 4-aminotetrahydrobenziothiazoles having gamma-aminobutanoic acid (GABA)-uptake inhibiting activity and thus useful in the treatment of analgesia, psychosis, convulsions, anxiety, epileptic disorders or muscular and movement disorders, such as spastic disorders or symptoms in Huntington's disease or Parkinson disease.
    Type: Grant
    Filed: October 5, 1999
    Date of Patent: January 16, 2001
    Assignee: H. Lundbeck A/S
    Inventors: Erik Falch, Jens Kristian Perregaard, Arne Schousboe, Povl Krogsgaard-Larsen, Bente Frolund, Sibylle Moltzen Lenz
  • Patent number: 5998613
    Abstract: The present invention relates to novel 4-aminotetrahydrobenzisoxazoles or 4-aminotetrahydrobenziothiazoles having gamma-aminobutanoic acid (GABA)-uptake inhibiting activity and thus useful in the treatment of analgesia, psychosis, convulsions, anxiety, epileptic disorders or muscular and movement disorders, such as spastic disorders or symptoms in Huntington's disease or Parkinson disease.
    Type: Grant
    Filed: August 5, 1997
    Date of Patent: December 7, 1999
    Assignee: H. Lundbeck A/S
    Inventors: Erik Falch, Jens Kristian Perregaard, Arne Schousboe, Povl Krogsgaard-Larsen, Bente Frolund, Sibylle Moltzen Lenz